IHC analysis of the proliferation marker Ki-67 and the apoptosis marker cleaved Caspase-3 revealed no difference in cancer cell proliferation or apoptosis in metastatic colonies between the combination-treatment and vehicle-treated groups (Supplemental Figure 14, A–C). Here, MKI67 is linked to cancer.